EDMONTON — An Alberta government agency is taking issue with the fact that a cold remedy company is using it to promote a study on one of its products. Alberta Health Services says Afexa Life Sciences (TSX:FXA) placed ads in newspapers suggesting the government agency is researching the effects of Cold-FX on children’s colds and flus. The ad, which includes the Alberta Health Services logo, seeks children between the ages of three and 11 to take part in a trial.
In a news release, Afexa lists Dr. Gerry Predy, Alberta’s senior medical officer of health, as one of the study’s clinical investigators. Roman Cooney of Alberta Health Services says the agency has nothing to do with the research and Afexa was wrong to place the ad and to use its logo or Predy’s government title.